8/3/2018Acticor Licenses Stroke Medicine to CMS in China and Select Asian Mark...

8/2/2018Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar in C...

8/1/2018SMIA to Hold Meeting Seeking Feedbacks on the Upcoming National Level ...

7/31/2018Korea's SillaJen and Medytox Prepare for China Business Takeoffs

7/27/2018CNDA Announces Adjustment of Drug Clinical Trial Evaluation and Approv...

7/27/2018Recent Executive Moves

7/27/2018Neovii Licenses Transplant Drug Grafalon In China And Japan

7/27/2018Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Tocilizum...

7/27/2018I-Mab and ABL Bio Announce Partnership on Novel Bispecific Antibodies

7/26/2018CBT Pharma Initiates Phase 1b Trial for Anti-PD-1 Antibody Drug

7/26/2018First National Drug Supply Consortium Formed under Government Guidance

7/26/2018SMIA: Urban and Rural Resident BMI Programs To Be Uniformed in 2019

7/26/2018MSD Announces Chinese Approval of Its Blockbuster Anticancer Drug Keyt...

7/26/2018China Presses Pharma Cos to Lower Anticancer Drug Prices As Prevalence...

7/25/2018Betta Pharma to Reduce Price of Anticancer by 4% after Government Talk...

7/25/2018WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection

7/25/2018Sanofi Gets Chinese Approval of Its MS Drug Audagio

7/24/2018Bayer Wins Chinese Approval of Hemophilia A Drug

7/24/2018XiAn Janssen's HIV Drug Prezcobix Approved in China

7/24/2018Novartis Oncology Launches TPO-RA Agent Revolade in China

7/24/2018Tencent Licenses WebMD Contents for Provision thru WeChat

7/24/2018BeiGene Reports Progress of Pivotal Trial for Anti-PD-1 Antibody in Ho...

7/23/2018Janssen's Yi Ke Granted Indication Expansion to CLL/ SLL in China

7/20/2018CNDA Issues Guiding Principles for the Acceptance of Overseas Clinical...

7/20/2018WuXi STA and Antengene Sign Development and Manufacturing Agreement

7/19/2018SAMR Seeks Comments for Draft Document on Medical Institution Formulat...

7/19/2018Tasly Licenses China Rights of Kidney Disease Drug from EA Pharma

7/18/2018New Report: China's CDMO Market to Boom by 2021

7/18/2018Mesoblast Enters Into Strategic Cardiovascular Alliance for China With...

7/17/2018Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial

Page:135/334 Total number of articles:9999: [First][<<] [133] [134] [135] [136] [137] [>>] [End]